http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053967-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49826c9dea952ee9ea088e5e2c8f5ae4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2004-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73975b8b5c52116069c5e242bab0827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a6de449205481d5b54d4d96bdfeb421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23119fb36d632ee5163cc5c795e117a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_343b9011c08572abc08cc274d526fee1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b348f377bf716ab5030c07d29ac3ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c9cb2641bfdd6300ee439ef9b8c248 |
| publicationDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005053967-A1 |
| titleOfInvention | Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| abstract | The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas. In a related aspect, the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the level of expression of one or more nucleic acid molecule markers. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10767214-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254985-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008145852-A1 |
| priorityDate | 2001-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 939.